Protara Therapeutics Inc (NASDAQ: TARA) Has Decreased By 6.83 Percent This Year. Is It A Better Buy Than Others?
Protara Therapeutics Inc (NASDAQ:TARA)’s traded shares stood at 0.37 million during the last session, with the company’s beta value hitting 1.37. At the close of